Stanley Cohen Innovation Fund
Stanley Cohen, Vanderbilt biochemist who won Nobel Prize, has died
Feb. 6, 2020—Stanley Cohen, a legendary Vanderbilt University biochemist who was awarded the Nobel Prize for the discovery of epidermal growth factor and its receptor, died on Feb. 5 at the age of 97.
Toxin floats on lipid rafts
Apr. 23, 2018—The bacterium H. pylori is a leading cause of stomach cancer, and Vanderbilt researchers are studying how one of its toxins gets into cells.
Researcher targets peanut allergies with Cohen Fund support
Oct. 12, 2017—Scott Smith, M.D., Ph.D., assistant professor of Medicine, has received a 2017 research award from the Stanley Cohen Innovation Fund to test a new therapeutic strategy for peanut allergies. Smith's research could fundamentally change allergy treatment.
Call for applications: 2017 Stanley Cohen Innovation Fund
Feb. 28, 2017—The Vanderbilt University School of Medicine is now soliciting applications for research awards from the Stanley Cohen Innovation Fund.
New fund honors spirit of Cohen’s innovative research
Aug. 25, 2016—When Tom Daniel, M.D., joined the Vanderbilt University faculty in December 1986, Stanley Cohen, Ph.D., had just been awarded the Nobel Prize in Physiology or Medicine for his discovery of epidermal growth factor (EGF).